Inactive Instrument
Raptor Pharmaceutical Corp Stock
Stocks
US75382F1066
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 61 | 2016-10-24 |
Kim Lee
IRC | Investor Relations Contact | - | 2014-10-22 |
| Corporate Officer/Principal | 64 | 2013-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gregg Lapointe
CHM | Chairman | 67 | 2015-07-31 |
Paul Hoelscher
BRD | Director/Board Member | 61 | 2016-10-24 |
Timothy Walbert
BRD | Director/Board Member | 59 | 2011-04-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.03% | +2.30% | +54.92% | +111.78% | 55.58B | |
| +2.72% | +3.06% | +53.28% | +47.85% | 43.47B | |
| +1.05% | +2.59% | -13.88% | -17.70% | 22.64B | |
| +1.05% | +2.87% | +0.05% | +397.05% | 20.96B | |
| +3.81% | -4.13% | +16.62% | -30.70% | 15.79B | |
| +0.15% | +0.50% | +9.10% | -40.04% | 15.3B | |
| -0.74% | +0.93% | +27.31% | +178.62% | 13.45B | |
| +5.27% | +6.41% | +21.05% | - | 11.74B | |
| +1.61% | +1.17% | +90.79% | +212.97% | 10.96B | |
| Average | +1.75% | +0.26% | +28.80% | +107.48% | 23.32B | |
| Weighted average by Cap. | +1.67% | +1.60% | +33.67% | +100.20% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
